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Episode 47: Preparing for Act Three 
Chris Dall: [00:00:05] Hello and welcome to the Osterholm Update: covid-19, a weekly 
podcast on the covid-19 pandemic with Dr. Michael Osterholm. Dr. Osterholm is an 
internationally recognized medical detective and director of the Center for Infectious 
Disease Research and Policy, or CIDRAP, at the University of Minnesota. In this 
podcast, Dr. Osterholm will draw on more than 45 years of experience investigating 
infectious disease outbreaks to provide straight talk on the covid-19 pandemic. I'm Chris 
Dall, reporter for CIDRAP News, and I'm your host for these conversations. 
 
Chris Dall: [00:00:42] Last week on the Osterholm Update podcast, Dr. Osterholm 
envisioned the coming weeks and months of the covid-19 pandemic as a four chapter 
story, with each chapter addressing our current mindset and the different challenges 
facing us. This week, we're going to continue on our literary theme, this time using the 
analogy of a three act play. The first act of the pandemic play saw the introduction of the 
novel coronavirus, the first wave of infections and lockdowns, and a premature 
reopening as people thought that the worst was behind us. The second act was marked 
by a big summer wave of infections, followed by an even worse wave in the fall and 
early winter that saw unprecedented numbers of cases, hospitalizations and deaths. 
Then two new plot points: covid-19 vaccines and dangerous coronavirus variants were 
introduced at the end of act two. And now we're in the second intermission waiting to 
see how those two plot points play out. It's an imperfect analogy, but on this March 11th 
episode of the Osterholm Update, we'll be exploring how this third act of the covid-19 
pandemic may unfold, looking at how those two key plot points, the vaccines and the 
variants, will affect the storyline. Within this discussion, we'll also talk about the CDC's 
recent guidelines on what fully vaccinated people can do and look at how vaccine 
inequity could extend the third act of the pandemic. We'll also answer a listener email 
about vaccinated residents of congregate settings and highlight a pandemic act of 
kindness from one of our listeners. But first, we'll begin with Dr. Osterholm's opening 
comments and dedication. 
 
Michael Osterholm: [00:02:11] Thank you, Chris, and welcome to all of you to another 
episode of the Osterholm Update. We very much appreciate our podcast family that 
joins us week after week. And if you're new to this podcast, we hope that you find 
something that you can gain from this podcast. And even to the extent that you begin to 
feel what so many of us who are weekly participants in this activity feel with regard to 
coming together, sharing information, sharing our feelings and what's happening and 
how we're going to get through this pandemic. Again I want to thank the crew for all the 
work that they do to help put this together. It really is a team effort. And as I've said 
many times, there's no I in team and I appreciate that so much. And I'm going to 
comment at the end of the podcast about you. About the audience that has made this 
podcast so important to so many of us. And so I can't say enough about how you have 
made the podcast turn out to be what it is. In terms of dedication this week, it seemed 
very natural for the dedication that we're about to share with you. As you may know, the 
UN Women announces the theme for the International Women's Day, which was this 
past week, March 8th, 2021, as 'women in leadership achieving an equal future in a 
covid-19 world'. The theme celebrates the tremendous efforts by women and girls 
around the world in shaping a more equal future and recovery from the covid-19 
pandemic. In addition to persistent pre-existing social and systemic barriers to women's 
participation and leadership, new barriers have emerged with the covid-19 pandemic. 
We all understand that across the world, women are facing increased domestic 
violence, unpaid care duties, unemployment and poverty. Despite women making up 
the majority of the front line workers, there is still a disproportionate and inadequate 
representation of women in national and global covid 19 policy spaces. We have to 
understand that the women have done so much under such a challenging situation to 
help us move through this covid-19 pandemic. And it's really based on what I would call 
this important theme that I consider the dedication for this week's episode. As most of 
you know by now, if you've been listening to this podcast, one of the most special gifts, 
if not the most important of my childhood, was a relationship I had with Nana, the co-
owner of the newspaper where my father was a photographer. She was in her mid 
forties when I was born. She had one daughter and then essentially had me. I became 
her adopted son. And she in turn became the mother of my soul. Her spiritual DNA is 
still in every cell of my body, and it literally helped shape the very values I cherish today. 
She was the essence of a Renaissance woman, having an MA degree in journalism. 
She was a world traveler and fluent in multiple languages. She loved learning. Oh, did 
she love learning. Over the course of twenty plus years, she died when I was twenty 
seven, we shared hundreds and hundreds of hours of soul searching conversations and 
she wrote me hundreds of letters and notes that would appear in the mail, even though 
her house was just eight blocks from our house. She also gave me her copies of The 
New Yorker, which included the section entitled 'Annals of Medicine: The Outbreak 
Medical Mystery Stories' by Burton Roueche that captured my eternal attention towards 
becoming an epidemiologist. In the spirit of the International Women's Day celebration, I 
dedicate this podcast with all my heart and soul to you, Nana. Now, before we move on 
past this, we do have one other very important piece of information we must share. This 
has become somewhat of a point of interest amongst many of you. And for those in the 
northern hemisphere, let's celebrate. For those of you in the southern hemisphere, I'm 
doing everything I can to share the warmth of the light here with you. We are now at the 
most dynamic days of the year in terms of increase in light length for the Northern 
Hemisphere. It's notable that for today's podcast we will actually have eleven hours and 
forty two minutes of sunlight. Hard to believe, but we've gained twenty two minutes 
since last week and now we're at two hours and fifty seven minutes of light gained since 
the winter solstice. And for the next several weeks the gain will continue to increase 
ever so slightly with twenty three/twenty four minutes, respectively, gained over the next 
two weeks. And then the gain slows down, we'll still have more gain but the gain slows 
down now from the vernal equinox or that March 20th date in the Northern Hemisphere 
in 2021, and as we move towards then the June twenty first date when it's the first day 
of summer. So that daylight's come and guys, it's getting there more and more. For 
those in the Southern Hemisphere, we share it with you. And for those of us in the 
northern hemisphere, oh, it feels good to see the light of day. 
 
Chris Dall: [00:07:42] As I noted in the intro, the three act play analogy is imperfect, but 
it does feel like we are in the second intermission here in the United States waiting to 
see how this third act unfolds. So let's start with one of the plot points, the vaccines. We 
now have more than 61 million Americans who received at least one dose of the 
vaccine, more than 32 million who are fully vaccinated. And the rollout is picking up 
steam. So, Mike, is the current pace of vaccination enough to lessen the impact of the 
surge in cases that you see coming? 
 
Michael Osterholm: [00:08:11] Every dose of vaccine is a gift. Every dose of vaccine 
makes a difference. And so from that perspective, of course, the more doses we get 
out, the more doses that people get in their arms, the better we all are protected. But we 
have to put that into some perspective. If you look right now, globally, there's been 
about three hundred and ten million vaccine doses that have been administered 
worldwide. Now, that sounds like a lot. But again, remember, we have eight billion 
people. And for most of these vaccines, it's a two dose approach. So that 310 million is 
just starting to scratch the surface on a global basis. If you look at by country and doses 
per hundred people right now, Israel leads the world at about ninety nine point seven 
doses per 100 people, which is remarkable. And again, remember a dose is only half of 
the full vaccination, if it's, in fact the Pfizer or Moderna vaccines. If you're looking at the 
other countries the Seychelles, the UAE, the United Kingdom, the Maldives and then 
the US are in that order inn terms of the most doses delivered. We're at about twenty 
seven point eight doses per hundred people delivered in this country. If you look at it by 
doses by one hundred people by continent, North America surely leads the way at 
sixteen point six doses per hundred people. Europe is at nine point seven, South 
America at four point three, Asia at two point five, Africa a dismal 0.4 and Oceania, a 
dismal 0.2. So from that perspective, we can see that there is not equal distribution of 
vaccine around the world. In the United States, we're administering a little over two 
million doses per day, which most of that still is the two dose vaccines, the Moderna and 
the Pfizer, with only a limited amount of J&J vaccine available. Approximately one 
hundred and sixteen million doses have been delivered. And as you pointed out earlier, 
Chris, there has been 92.1 million doses administered. That includes sixty one million 
people received at least one dose and thirty two million people have been fully 
vaccinated. This is about a quarter of the people over 18 having received at least one 
dose. That is very good news. We must celebrate that. But it's a start and only a start. 
Among those greater than sixty five years of age, which you've heard me talk about on 
numerous occasions on this podcast and why it is so important to get this group 
vaccinated because of the increased risk for serious illness, hospitalization or death. 
And among that group of sixty five years of age and older, thirty two million have 
received at least one dose, which is the equivalent of about 60 percent of the population 
of those over sixty five years of age, and also twenty two million remain unvaccinated. 
So we still have a long ways to go in this group. And over the course of the next weeks, 
even with two million plus doses a day arriving to distribution centers and knowing that 
you have to, in a sense, cut that dosage in half in terms of number of people vaccinated, 
you can see we saw the long ways to go to get to this twenty two million that remain 
unvaccinated over the age of 65. And also remembering that you have a situation where 
many other people have now been included in the state's hierarchy for getting vaccine 
so that we have a lot of pressure on getting it to those under sixty five who have a 
number of other conditions. I've heard from many of you who have had concerns or at 
least questions about our approach of prioritising those 65 years of age and older. And 
again, I'll come back and talk about that more later. But it's all about who and how do 
we save the most numbers of lives. And so we'll come back to that later. And one 
additional point in the United States, over two hundred thousand people have now 
received the J&J or Johnson vaccine, the single dose vaccine. We are so aware of and 
want to continue to push forward the importance of looking at disparities in vaccination. 
And while for the short term of trying to just respond to the B117 surge, which is coming, 
which we'll talk about in a moment, we have to stay focused on the disparities in 
vaccination and how do we increase those levels, particularly as we look at the 
consistent pattern across states of black and Hispanic people receiving smaller shares 
of vaccination compared to their shares of cases and deaths and compared to their 
shares of the total population. For example, in Arizona, 13 percent of the vaccinations 
have gone to Hispanic people, while they account for 36 percent of the cases, thirty one 
percent of the deaths and thirty two percent of the total population in the state. Similarly, 
in Maryland, black people have received 17 percent of the vaccinations, while they 
make up 33 percent of the cases, thirty five percent of the deaths, and 30 percent of the 
total population. We know that white people have received a higher share of 
vaccinations compared to their share of cases and deaths and their share of the total 
population in most states reporting data. Yes, we do know we have a lot of work to do 
on vaccine hesitancy, but we also have some fundamental issues we have to deal with 
in just the systematic availability of vaccine based on a already well recognized system 
of racial and ethnic disparities. So I just want to put that out there. I want to be clear to 
you that once we get through this B117 surge, the age situation, while still very 
important, this is where 80 percent of the cases that go on to get serious illness and die 
occur is in those sixty five years of age and older, we also have to be committed to 
dealing with the disparities that we're seeing right now. I do believe the administration 
will deliver on their promise to have enough vaccine for every adult in this country by the 
end of May. That is very good news. And now what we have to do is just manage our 
ability to get through to May, making sure that we don't let that B117 surge in particular 
impact people before they get that access to that vaccine.  
 
Chris Dall: [00:14:39] While there's been no recommendation yet in the US to extend 
the interval between the first and second vaccine doses, as you have been calling for, 
Canada's Vaccine Advisory Group last week called for extending the interval from six 
weeks to four months. So, Mike, what was their basis for that decision? 
 
Michael Osterholm: [00:14:56] Chris, the group they're referring to is known as the 
National Advisory Committee on Immunizations in Canada as part of the government of 
Canada. They're very similar to our Advisory Committee on Immunization Practices at 
the CDC here in this country. They have a stellar reputation for their recommendations 
that they've made over the years with very thoughtful and detailed analysis of the data 
that's available to make those recommendations. And they, like our colleagues in 
England, have come up with a very different conclusion than we have put forward here. 
Let me just share with you the report that came out this past week entitled 'Rapid 
Response: Extended Dose Intervals for covid-19 Vaccines to Optimize Early Vaccine 
Rollout and Population Protection in Canada'. And I won't go into all the detail of the 
report, but let me just summarize some of the points that they made. They said, "The 
Committee has considered evidence from recent scientific studies on efficacy and 
effectiveness of covid-19 vaccines in preventing various health outcomes such as 
infection, symptomatic disease, hospitalizations and deaths from covid-19. While the 
studies have not yet collected four months of data on vaccine effectiveness after the 
first dose, the first two months of real world effectiveness are showing sustained high 
levels of protection." They go on to say, "Short term sustained protection is consistent 
with immunological principles and vaccine science, where it is not expected to see rapid 
waning of a highly effective vaccine in adults over a relatively short period of time. 
Extending the interval between doses were shown to be a good strategy through 
modeling, even in scenarios considering a six month interval and in theoretical 
scenarios were waning, protection was considered." They then went on and 
recommended that in the context of limited covid-19 vaccine supply, jurisdictions should 
maximize the number of individuals benefiting from the first dose of vaccine by 
extending the interval for the second dose of vaccine up to four months. Now, they 
reviewed the data. The issue that I've urged on our country do and has not done yet. 
And I think that I have great faith in this group and what they did and how they 
considered the information, whether they considered was short term protection 
indicative of what would be long term protection for even six to eight weeks, the period 
that we have continued to talk about relative to the B117 surge. Not months, but weeks. 
They've talked about four months. Would, in fact, this situation encourage more variant 
development? More data continues to come out and modelling showing that one dose 
of vaccine is much more likely actually to reduce the potential for variant development 
than would, in fact, natural infection, which is going to be at higher levels if we don't 
vaccinate more people. The data from England has been very impressive and where 
amongst the vaccinees, there's been no evidence of variants developing in that 
population and many of those individuals got a single dose of vaccine. So I think that 
what we see here is this continuous situation where each day grows shorter and shorter 
in terms of the time the number of individuals we can get vaccinated in that sixty five 
year and older age group. Unfortunately, we are now doing public policy by soundbytes 
in the media. I'm part of it, I get it. But our government, as much as I appreciate what I 
think has been an incredible effort by this administration on the vaccines, they are failing 
us on this one part. All we're asking for has been a careful review by an object body that 
would look at all the data of what do we know about the immunology? What do we know 
about the epidemiology? What do we know about the modeling studies? What do we 
know about the virology relative to variants? And put this together and compare that to 
what the risk is right now of a B117 surge, which we'll talk about in a moment. And that 
hasn't happened. Instead, we just have this kind of trading comments in the media, 
which I think is so unfortunate and not a good way to develop public policy. There is a 
lot of support out here right now for just an evaluation of this. Don't leave it to one or two 
or three people just to pronounce that this is not going to happen. And as I have said 
from the very beginning, if we cannot demonstrate the relative effectiveness of the 
vaccine or the anticipated effectiveness and that that would actually cause more 
problems, then I'm the first one to say, you know, keep doing what we're doing. But I 
watch all these other groups- is the science in Canada that different? Are they just not 
getting it? The scientists in England, are they just not getting it? What are we missing? 
We're missing a legitimate, comprehensive review of the data to address an emerging 
problem. I care about what's going to happen with 1351. I care what's going to happen 
with P1. And that's where I hear comments made all the time, "We can't do this because 
we may allow those variants to emerge." I can tell you right now that B117 is sitting on 
our doorstep and is ready to bust through the door. It's not ready to knock. That's what 
we're up against right now. So I hope that we will see the light where we'll at least have, 
at least have, a process quickly for understanding what this all means and bringing 
together the experts from all the different locations. You know, I've seen three recent 
modeling studies. Every one of them supports the fact that using the deferred second 
dose for a short period of time versus the first dose would save lives. How can you 
ignore those data? How can you just dismiss them? So I hope that we do see a change 
in the approach by this administration and at least evaluate this. For if they don't, I fear 
that we will needlessly lose thousands of lives in the weeks ahead. 
 
Chris Dall: [00:21:17] You and your collaborator, Mark Olshaker, have a new article out 
in Foreign Affairs on vaccine inequity in the current global covid-19 vaccine regime. 
How is the issue of vaccine inequity going to affect how this third act plays out? 
 
Michael Osterholm: [00:21:30] When this pandemic began, there was a recognition 
that we needed to supply the world's population with vaccine. We always knew that, but 
the reality was also that the high income countries would be at a great advantage. They 
had the money to not only develop the vaccines, but to buy the vaccines and distribute 
the vaccines. And so there was a group put into place, which we've talked about before 
on this podcast, COVAX, which was an attempt to bring resources under the auspices 
of the WHO and various sources of support from governments and foundations to help 
supply the vaccines that we need to the low and middle income countries. It was 
interesting that, you know, a goal of 20 percent of the population to be vaccinated in the 
first year was considered to be a, I guess, doable but also acceptable goal. And that all 
changed in November. From my perspective, everything prior to November was about 
humanitarian response. And it should have been, we owe it to the world to provide them 
with these safe vaccines that are effective. Once the variants emerged, it's been a 
whole new ball game. Because not only are we worried about the variants that cause 
more transmission of the virus or more serious illness, but now we've already been 
talking about it for weeks now about what happens with those variants that are able to 
evade the immune response of either vaccines or natural infection, or at least do it in 
such a way that it minimizes their effectiveness. And now, of course, we have to 
consider where might these variants come from? What will be the source of the variants 
that will challenge our vaccines next month, six months from now, a year from now, two 
years from now? It's going to be coming from natural infections in our communities. And 
I'm talking about communities around the whole world. So if we don't minimize 
transmission of this virus throughout the world, these viruses are going to spin out of 
these low and middle income countries where transmission will continue. And if we don't 
limit that transmission, these viruses will be on our shore, they'll be in our population 
and they will threaten our vaccines. Now, that sounds very selfish and in many ways, 
what has been called 'vaccine nationalism'. Well, it is. But it's also true for everyone in 
the world. We have got to stop the transmission of these viruses so that we don't see 
the kinds of variants develop that challeng vaccines. So this article was really about the 
recognition that we need to rethink what we've accomplished to date in terms of 
planning for developing production capacity and envisioning how we might vaccinate 
the low and middle income countries. We need a Marshall Plan, maybe a Manhattan 
project. Because whatever we do there will pay dividends to everyone on the face of the 
earth, everyone. And so I can't say in any more strong terms that what I see happening 
right now, while it is, I think, well intended, and I mean that in the finest way, people 
want to help. But we've got to have a grand plan here. We have got to figure out how 
are we going to take on the world's need for vaccine. That means it doesn't result in 
enough vaccine arriving 10 years from now or five years from now. We need it now. And 
there is not enough capacity to do that. It would have to take on a whole new vision of 
how we would manufacture these vaccines, how we distribute them, how would we 
develop plans to deal with vaccine hesitancy in other countries of the world? How would 
we have enough syringes? How would we have all these things? So I hope that we see 
that the reason for doing this surely is humanitarian, but it's also strategic. Boy, is it 
strategic. It's about protecting vaccines for the world. And those discussions are not 
really happening yet. They need to and I think otherwise we'll be paying a price for 
supporting and protecting our vaccine effectiveness.  
 
Chris Dall: [00:26:12] Now to the other plot point that's going to shape how this third act 
plays out, variants. We're currently seeing B117 fueling surges in Europe. Is this a 
preview of what we're likely to see here? And how concerned are you about what Brazil 
is experiencing with the P1 variant? 
 
Michael Osterholm: [00:26:30] Well, anyone, again, listening to this podcast over the 
past 8 to 10 weeks knows of my grave concern about the variants and specifically the 
B117 now in North America. And while I'm sure for many of you it seems like I've been a 
broken record and you keep saying, "Yeah, you keep talking about it, you keep talking 
about it and you keep talking about it, but what's happening?" And even those saying 
you know, five weeks ago that it would take six or more weeks before we would see 
those start to develop really into a potential surge of cases in the United States, I 
regretfully have to tell you, we're beginning to see that happen and we shouldn't be 
surprised. We know, for example, now with additional studies that those who are 
infected with the B117 variant typically have higher viral RNA loads, their duration of 
infection is noted to be longer and that in a sense, the explanation biologically is still not 
completely clear, but it is absolutely clear epidemiologically that these people are 
transmitting at a much higher efficiency, 40 to 60 percent more efficient in transmitting 
the virus. If you look in the United States right now, the CDC is reporting three thousand 
thirty seven cases in forty nine jurisdictions. What is important here, it's now almost in 
every jurisdiction. The number of cases is almost immaterial because there's so little 
testing and particularly sequencing these viruses. If you look at the Helix Dashboard, 
this is the company that's doing a great deal of sequencing right now, more than 40 
percent of the cases in Florida, more than 20 percent of the cases in California, more 
than 25 percent of the cases in Texas are all B117. Up from what just weeks ago was 
one, two or three percent. And, you know, they go up, in some cases for a week or two 
they're more static, and they go back up again. If you look at wastewater testing, one 
group that's been reporting their data in Houston shows that B117 is spreading in that 
city quite quickly. We see 25 percent of the cases in Georgia are now B117. And this is 
a situation where the non-B117 cases continue to decrease and the B117 are starting to 
increase. So it looks flat. And that's exactly what happened in Europe, we've seen that 
before, this picture has happened before. But what happens is unless you're in 
lockdown like they have been largely and we'll talk about that in a moment, what 
happens is then roughly around 50 percent or more of the viruses being B117, you start 
to see very rapid growth of cases in the communities, often starting in children. This 
leads me to why my fears about what this might do, this variant, are now being realized 
in a place like Minnesota. I'm not in a place to get into great detail, but the Minnesota 
Department of Health has already announced a very rapidly growing outbreak of B117 
here in the state of Minnesota. And I've had the opportunity to review the data they've 
collected. I want to, first of all, just compliment them. The department has done an 
amazing job of contact tracing, follow up, putting together the epidemiology of these 
cases. They reported over the weekend in sixty eight cases, which represent truly many 
more infections in the community in an area, primarily in one county. But even since 
Saturday, that has expanded substantially in terms of where the transmission is. This is 
dynamic transmission. If you could see the plot of all the cases and the contacts, and 
the contacts, and the contacts and the level of infection transmission that's occurring 
right now, it is remarkable. I've not seen anything like this before. Not. You know, maybe 
if we didn't have people vaccinated for measles, we had a measles outbreak that would 
maybe be it. But otherwise, this is remarkable transmission. I've never seen influenza 
do this like this. And so the challenge we have right now is, is what's happening out in 
the public, is this idea that we're done, we're over, we're opening up everything. So now 
we have on top of the fact that we're having this transmission largely associated initially 
with schools, youth sports and then spreading in the community, is the fact that this has 
not yet resulted in a big increase in hospitalizations or big increases in cases as the 
other cases are going down, non-B117s. But this is just a matter of time before we see 
that turn, as we saw in Europe. And at a point where we're opening up everything right 
now, we could not be more inviting to this virus. This is a perfect storm. We've got this 
level of activity in Florida and we're about to see a major spring break event, pent up 
energy from a year ago. And we can tell you right now that if you look at hotel 
reservations, travel, etc., this is going to be a banner year there. So here in the United 
States, I have no doubt that this is going to start to take off. Could be a few more weeks 
yet for many areas. Some areas will get hit sooner than others. And it will start out 
largely in kids, which will be a challenge to those wanting to open schools again. We're 
going to reopen a lot of schools. And I think it's very possible that within several weeks 
of that, we could be closing them back down again. Not anything anybody wants to 
hear, but it's the reality of what likely will happen. The one thing that we've got going for 
us in this is just to keep vaccinating our older populations as much as we can to reduce 
those serious illnesses, those hospitalizations and deaths, because these kids are going 
to start transmitting to mom and dad, which we're already seeing, which will then 
eventually go to grandpa and grandma or uncle and aunts. And so I just know this is 
coming. It's closer now than it was last week, unfortunately. The hurricane analogy still 
applies now. We definitely can see really dark grey clouds right up to the beach. And 
what will happen is unclear. How will we respond? You know, what this virus is going to 
do yet is still unclear. But I can tell you, we are going to see a sizable number of B117 
cases over the next few weeks to few months at a time when we are giving it every 
opportunity to spread. As far as B117 and the rest of the world, let me just comment on 
that, because, again, this is the road map. This is what we should be looking at. Overall, 
B117 is spreading significantly in twenty seven European countries monitored by WHO. 
And it is the dominant variant right now and the dominant virus in at least ten countries, 
the U.K., Denmark, Italy, Ireland, Germany, France, the Netherlands, Israel, Spain and 
Portugal. And at this point, I'd rather than go through each country and just give you 
what's going on. It varies depending on what degree of lockdown they've been in. I've 
shared with you week after week, the extent of lockdowns in Europe that have been 
going on since Christmas which most people are not aware of. In some cases, some 
countries are not what they call locked down, but when you start looking at all the things 
that are closed, the activities that are not permitted, they surely have limited their activity 
in a way that would help slow down transmission. Some countries have been 
particularly hard hit. Right now, the Czech Republic is in tough shape. We're beginning 
to see major increases in the Scandinavian countries with this issue. And I just know 
that it will only be a matter of time before we begin to see some of that same activity. 
We're also now beginning to see B117 activity in Asia with cases in Japan and the 
Philippines starting to increase. The prime minister in Japan has warned that there 
could be a potential surge driven by B117, and that he's likely to extend a state of 
emergency to Tokyo for that reason. So the whole world is going to be dealing with this. 
Our difference is we think we're done. And I don't know what else to do other than just 
remind people that get vaccinated or please understand you're still at risk. In terms of 
the other variants, I don't really know what to say about P1 right now in Brazil. Other 
than that, it's scary as hell. What we're seeing in Brazil right now is a huge challenge. 
And anyone who's following this closely realizes we're still hurting to get good 
information out of Brazil. But they are really at an all time high in terms of the 
transmission of virus there. It's now sweeping through a number of cities in Brazil. They 
have now just this past Tuesday, recorded more deaths in a single day toll than the 
entire pandemic before this. And the governments themselves are indicating the 
severity of this situation. This appears to be P1, although I think we have to be careful, I 
think B117 may be part of this also. But what it's telling us is that these other variants, 
the P1 and the B1351 are not done with this either. And again, I just come back, this is 
the one, remember, that can impact on the protection afforded by the vaccine and/or 
natural immunity. And so I think we have to sleep with one eye open for the months 
ahead knowing that we could get through B117, but still have to deal with these other 
variants. They're not going away. And the more people that get infected, as I said, the 
more variants you're going to see. So as I've been saying for some time, the variants 
are the game changer. And people ask me what inning we're in right now, I say rather 
than the bottom of the third or top of the fourth, I say we're in the first two minutes of the 
first quarter. And they look at me kind of funny, like, well, you don't have quarters in 
baseball. My answer is, you're right. We're in a whole different ball game right now. And 
I think the variants are it. So it's our vaccine, our efforts to reduce transmission against 
this evolutionary advantage that these viruses have. And right now, I am hopeful, but I 
can't say with certainty who's going to win this one in the short term or the long term. 
 
Chris Dall: [00:37:06] So, Mike, to follow up on a point you were just making, despite 
the warnings from the CDC about the still high levels of new cases in the U.S. and the 
dangers of the variants, a growing number of states are removing their covid 
restrictions. They're lifting the mask mandates, they're ending the capacity limits on 
restaurants. How big a role is that going to play in how this third act plays out? 
 
Michael Osterholm: [00:37:29] I only know it will play an important role, how much, I'm 
not certain. For example, the infection in kids is really something very different than 
we've seen before. And yet right now, we're in the biggest push we've been in since 
March of a year ago to reopen all schools. Well, my concern is we're going to see a lot 
of transmission in kids. We're going to have some serious illnesses there. And then the 
virus is going to move into mom and dad. And at that point, hopefully not into grandpa 
and grandma. But if you've seen what happened with college students once they got 
infected this past year as a large group, it did move through the community subsequent 
to the infection on campuses. These kids hold the very same potential. And I just got 
done describing this outbreak here in Minnesota. Kids are feeling this, but the older 
individuals who are at much more increased risk for serious disease, hospitalization and 
death are going to pick it up from these kids. So there right there is one conflict and 
nobody who is trying to get schools open wants to hear anything from people like me 
about the schools being a problem coming down over the course of the next several 
months. The second thing is just opening up everything. I understand that. I get it. 
People are tired, people really are tired, they're frustrated. They're financially in such 
bad places. They're hungry, they haven't had enough food. And so to try to explain to 
them now that something's going to happen, nobody wants to believe that. I am 
resigned to the fact that very few people are going to take any of these messages that 
people like myself are sharing very seriously. They're not. But then that gets me back to 
that old cliche- why are we so good at pumping the brakes after we wrapped the car 
around the tree? And I'm so afraid that that's what's going to happen, because in 
Europe, the B117 when it started really was on the back of the previous surge that was 
not due to B117, but because they were in a lockdown phase, it kept the transmission 
minimized in Europe, even though they still had a lot of transmission. So I think at this 
point, this is why as individuals, all of you listening on this podcast, take care of yourself. 
You do not want to be the person that gets infected two days before you have your first 
dose of vaccine. Live for that moment. Do what you can to keep yourself safe. If you've 
not been infected to date, please keep it up. Not much longer, this B117 surge is not 
going to last for months and months. But you don't want to between now and May, for 
example, become infected, be seriously ill and even die. So I hope that even though 
governments are going to loosen up, they're going to allow life to get back to what it 
once was, it won't be that because the virus will be there. And I just hope that we can 
get as many people through that time period to vaccine and make certain that they don't 
become a statistic. 
 
Chris Dall: [00:40:45] So going back to vaccines, the CDC this week came out with 
new guidelines for fully vaccinated Americans, which is something you've been calling 
for on this podcast. Mike, what do you make of those guidelines? 
 
Michael Osterholm: [00:40:57] Well, first of all, let me congratulate CDC on actually 
putting these guidelines out, and before I give you my conclusions about them, let me 
just tell you that I have received many, many emails about these. And there are those 
that come from what I'd call a more conservative bend that think that the restrictions are 
still far, far too much, loosen up much more. And then I have a number of emails from 
people who are really concerned about the impact of these and think that they went far 
too much in the way of relaxing requirements to minimize transmission. And when you 
get basically both sides really feeling that the same document represents two different 
things, I call that the Goldilocks document, it's probably pretty good. In this case, this 
document surely can be improved. And I have to give credit again to the CDC and to Dr. 
Rochelle Walenksy, who made it very clear in releasing that this document be 
constantly updated as new information comes in. And so this isn't one of those 
documents that will be on the table static for the next year, live by it. I think as we get 
more experience, it will basically be expanded substantially. First of all, the document 
does recognize that vaccination in of itself is still the most important thing we can do to 
protect ourselves long term and in a way that allows us to get our lives back. And we 
have to encourage people to do that, to get vaccinated. And if we tell them, "Oh, no, 
you're going to wear your mask and you're still going to be quarantined or isolated or 
not able to join the community, even though you've been vaccinated with highly effective 
vaccines," that doesn't play. That won't play. The public will not buy that. That's what I 
said on multiple occasions on this podcast. And I think their first step was to say, you 
know, if you are vaccinated and you visit those from a single household who are at low 
risk for severe disease, i.e., grandpa and grandma, kids and grandkids, and you know 
where my heart goes, I'm there, then in fact, you can do that. Now, I would have liked to 
see them gone further than they did in some of the areas around congregate living. 
We'll talk about that more in a moment. I know we have a question that's going to come 
up this week on that. I think they have to provide more direction on travel. That was the 
one that I think a lot of people thought that the document laid an egg and just said we're 
going to keep our very strict travel requirements in place. I understand why, some of the 
variant issues are key. How do you distinguish where you travel? Under what conditions 
and what variants might you encounter that could impact on how protected you are by 
your current vaccine? So in short, I would just say that I urge you to read these, they're 
on our website, this guideline. And I think that they're clearly coming and I look forward 
to additional iterations of this. And while some have been critical, again, they're too 
lenient, others have said they're basically still are far too strict, I think that they are in the 
right place. And I do believe that over the course of the next weeks to months, they will 
only get better. 
 
Chris Dall: [00:44:20] So as you just mentioned, we received an email last week on an 
issue that is connected to these new CDC guidelines and what fully vaccinated 
Americans can do safely. So here's an excerpt of what Jim wrote to us, "I have not been 
able to visit my wife Mary since last February, since she is in an assisted living facility 
for early onset Alzheimer's. She's vaccinated and I am vaccinated, yet I cannot visiter 
with full contact. She's not able to deal with six foot distancing and will fight to be able to 
hug me. I've been in contact with the CEOs of two large assisted living facilities and 
they informed me that the issue is that the CDC has not released any rational guidance 
in this area that the states can take and adopt a state policy." So Jim went on to note 
that staff at many of these facilities are being vaccinated at only a 50 percent rate, and 
said that in his view, vaccinated spouses are no danger to each other relative to the 
danger posed by unvaccinated staff. "I want to visit with my Mary," he wrote. So, Mike, 
do the CDC guidelines released this week address vaccinated people in congregate 
settings? And if not, do people in Jim and Mary's situation need better guidance? 
 
Michael Osterholm: [00:45:28] First of all, Jim, my heart aches for you and Mary. I 
can't imagine the painful situation that you experience trying to be close to your wife 
under such difficult conditions and not being allowed to do that. This is one of those 
examples where the CDC document doesn't provide clear and compelling statements 
about what to do. They said in the section on the impact of prevention measures in the 
context of vaccination, quote, "Furthermore, there may be certain activities that can be 
performed after vaccination, such as nursing home visitation as long as other measures 
are maintained," then the cite is CDC unpublished data. Well, I will take this statement 
to say on behalf of the Public Health Supreme Court, you have just won your decision. I 
hope that this long term care facility will allow you to hug your wife and hold her for as 
long as you want and take this statement right there. Now, they may say, well, "It's still 
not clear. It's not clear." This is where our human hearts have to be equally represented 
as much as our big brains, and you are so right about the fact there are so many 
workers right now in long term care who are not vaccinated. If you want to talk about 
risk, the two of you being vaccinated are absolutely such a low risk to that facility per 
their other risk. It seems to me to be just ridiculous that they would keep you away. So I 
hope for everyone listening out there who have similar situations to Jim and Mary that 
you are advocates for yourself or you help someone be an advocate for yourself or you 
be an advocate for someone else and continue to press this issue. If you're all 
vaccinated, absolutely you should be able to have physical contact in that long term 
care facility and feel that you're doing it safely. So I hope that you can report back to us 
in the very near future that that was successful. And I hope that you hold her tight and 
hold her for a long time. 
 
Chris Dall: [00:47:49] All right, going back into our e-mail bag here, we received a 
follow up email this week from Kevin who's question about participating in the 
Birkebeiner cross-country ski race was just a few weeks ago on the podcast. And for 
our listeners, your advice, Mike, was to tell Kevin to go for it. So, Mike, can you share 
Kevin's email with us and why you think it's important? 
 
Michael Osterholm: [00:48:12] Well, for those listeners who don't remember, Kevin 
inquired about whether he could actually participate in the national cross-country ski 
race called the Birkebeiner, the American Birkebeiner in Wisconsin and I'll talk more 
about that in a moment. And I gave him the advice that, in a sense, was about a 
winnable moment, that there were a lot of things that he could do to make certain that 
he didn't put himself at increased risk and the way the race was laid out, the same thing, 
and that he should do it. He should take that opportunity to do it in the safe manner. And 
these are the winnable moments I'm talking about. As I mentioned, this is one of the 
longest races in the country. It debuted in nineteen seventy three starts in Cable, 
Wisconsin, and goes to Hayward, Wisconsin. There are different races lengthwise and 
this year they did so many things to make it covid-19 save. They, for example, had a 
looped course. So you didn't actually end up going from cable to Hayward but came 
back around. They limited the number of racers. They spread it out over time. They had 
no audience there. It was all kinds of things they did. And first of all, my hat's off to the 
Birke for what they did and how they did it. This was what we are talking about by 
getting winnable moments. So Kevin sent us the following email back afterwards. "Dr 
Osterholm and CIDRAP team, I really appreciated hearing from you about the level of 
risk involved in skiing the Birke. I really didn't want to skip it and my worries were put to 
rest. I went down to Cable and had a great time. The Birke crew ran a great race and 
enacted a number of measures to ensure a safer event. It was broken up into five 
separate races, masks were used everywhere, but during the actual race they 
eliminated the need for transporting people around by looping the course back to the 
beginning, they had countless fluid available at the aid stations and skiers were allowed 
a window of time to start so they didn't need to be near others if they didn't want to. 
Although our results don't count for placement next year because different weather and 
snow conditions can have larger effects on time, I'm really happy with my race and 
confident I would have been able to move back into the elite wave if it were possible. 
More importantly, it was a festive event that capped a year of anxious training for many 
citizen skiers. And it provided a lot of folks with an outlet for and reminder of the things 
we can do. I even did a little physically distance outdoor tailgating in the parking lot 
afterwards, drinking and eating items I brought with me from the car. I drove down by 
myself that same morning. Out of an abundance of caution, I will get tested five to 
seven days after as well. Thanks again for doing this podcast. Sincerely, Kevin." I just 
have to say that this is one of those great moments. Everyone listening, please find the 
ways you can have your own Birke right now. And when you get vaccinated it will even 
get better. Thank you, Kevin, for your note. Thank you for the follow up. I'm so glad that 
you got to participate in this race. Congratulations to the Birke crew who obviously went 
out of their way to make certain that this was as safe as possible with regard to covid-19 
transmission. And these are the winnable moments. I hope all of you can find similar 
moments. If you're not yet vaccinated, there still are opportunities to do the things like 
Kevin did. And so I'm excited about that. And I'm going to be more excited when we can 
one day have it, when we're all vaccinated and feel completely protected in these 
environments. 
 
Chris Dall: [00:51:55] Now to one of our favorite parts of the podcast, the act of 
kindness update. This week we have an international act of kindness from a listener in 
Barcelona, Spain. Can you share with the audience, Mike? 
 
Michael Osterholm: [00:52:06] Well, this is indicative of this podcast family I talk about, 
we hear from people from around the world. And I can't tell you how much that means to 
us in the sense of how much you inform us and provide us with information about what's 
happened in your areas and and the cultures that you come from. So this one is from 
Maya. And thank you so much, Maya, for it. She says, "I live outside of Barcelona and 
have been listening weekly to the Osterholm Update. Thank you. Early on in the 
pandemic, my family organized several Go Fund Me initiatives to help people in 
Rwanda where my husband works, who were suffering from the economic impacts of 
the lockdown imposed there. Since I am a ceramicist, in January, I decided to organize 
an empty bowls fundraiser. When I lived in New York I participated in our local empty 
bowls fundraisers, but this was the first time I organized one and the pandemic 
complicated logistics. The local ceramics community donated one hundred and seventy 
handmade pottery bowls, each one beautiful and unique. My friends and I organized 
two separate outdoor socially distanced with the doodle sign-up events last weekend. 
People were invited to come and choose a bowl, we served a delicious soup in their 
bowl, make a donation and then keep the bowl. We raised over two hundred and fifty 
euros for a Barcelona based charity that supports the homeless. I was overwhelmed 
with the positive energy and support we had for this event. And I'm enclosing a video 
and a few photos. Best, Maya." And I have to tell you, the photos and videos were just 
incredible. So thank you. Again, creativity, kind heart, thoughtful. And this is what we 
can do. This is part of our pandemic of kindness. And so, Maya, all the way from 
Barcelona, Spain to Minneapolis and back, we thank you for sharing this and for what 
you did. And one day I want to come to Barcelona and I want to buy one of those bowls 
from you. They were quite remarkable. So thank you very much. 
 
Chris Dall: [00:54:15] And a reminder to our listeners, no matter what country you're in, 
if you want to share your pandemic act of kindness with us, please email us at 
OsterholmUpdate@umn.edu. Your closing thoughts today, Mike? 
 
Michael Osterholm: [00:54:29] Well, thank you again to all of you for spending time 
with us. It means everything to us, as I say weekly and I say sincerely every week. We 
know you have many other opportunities to get your information about covid-19 and the 
pandemic and how it's proceeding. And even if you always don't agree with me on 
certain issues, you're very kind and tolerant to stay with us. That's what families do. And 
I appreciate that more than I can tell you. I thought a lot about this particular closing this 
week, and it came in light of a series of emails I've received over the last several weeks. 
And so let me tell you a story, background, and then you'll understand why I've chosen 
what I have. First is the story about Harry Chapin for many of you in this podcast, you 
may never have heard that name before. Harry Chapin was an American singer, 
songwriter and philanthropist. As was described in several different books about him, he 
was one of the most beloved performers in music history. Harry Chapin died at the age 
of thirty nine, July 16th, 1981, in an automobile crash outside of New York City. He was 
on his way to do a fundraiser. I personally have been drawn to him while he was alive. 
His song, Cats in the Cradle to me has always been an anthem about how I want to be 
as a father. All 14 of his singles that released all became Hot Hits, a remarkable 
songwriter singer, and he fought to end world hunger like very few people did. He put 
his money where his mouth was and he worked hard. Person number two, that fits into 
this story, Pete Seeger, a folk musician that needs little introduction to most people on 
this podcast. Pete died at ninety five years of age on January twenty seventh, 2014 and 
having done fundraisers not long before he died. The 1950s, he was a member of the 
Weavers, a very famous folk singing group back then. And in the 1960s he became a 
prominent singer of protest music in support of international disarmament, civil rights, 
workers rights and environmental causes. He was the person who wrote Where Have 
All the Flowers Gone and made that famous. He also was the one that popularized We 
Shall Overcome, which became an anthem for the civil rights movement. Barack 
Obama called him America's Tuning Fork, and he believed in the power of song to bring 
social change. These two remarkable gentlemen had a conversation one night when 
they were both still alive and they were discussing why did they do what they did and 
how did they do it? And in particular, Harry was asking this of Pete Seeger. And Pete 
responded and said, you know, being committed to the good causes puts you in touch 
with the people, with the live eyes, the live heart and the live heads. And he said, you 
know, I'm not sure if anything I do makes a difference. But every night when I go to bed, 
I put my head down in that pillow and I know I spent the days with the good people. 
What a powerful statement. Well, why do I say that? Because a number of you have 
actually written me recently reading in the internet some pretty horrible statements 
about me or suggestions that my motivations and my ego are are not, in fact, consistent 
with what they believe is the reality. And they've asked me, "Why do you do this? You 
know what is it that makes you do this that you would have to put up with that kind of 
feedback?" And first of all, let me just be clear. I get so much positive feedback from 
you. I've told you over and over again as a podcast family, you have no idea what you 
do for all of us at CIDRAP. We all benefit immensely from you and your comments and 
your input. But, you know, I thought about it a lot. Why do I do this podcast? Why do I 
put myself out there knowing I'm going to get cut to pieces the next day. And it's 
because of you. You are the good people. When I finish a podcast, I know I've spent 
time with the good people and I hope you all take that seriously because it's you that do 
the acts of kindness. It's you that continue to struggle with the pain, the isolation, the 
loneliness, the mental health challenges, economic challenges, all of the things that go 
on with this pandemic. But you're good people. We hear it and see it every day. So I 
share with you the story of Harry Chapin and Pete Seeger in the context of I will never 
be them. Believe me, I have no misconceptions about that. But I do have a bit, a little bit 
of an understanding of what it means to be with the good people. So thank you very, 
very much. Have a good week. Have a safe week, be kind, be thoughtful and most of 
all, love yourself. Thank you. 
 
Chris Dall: [01:00:02] Thanks for listening to this week's episode of the Osterholm 
Update, if you're enjoying the podcast, please subscribe, rate and review and be sure to 
keep up with the latest covid-19 news by visiting our website CIDRAP.umn.edu. The 
Osterholm Update is produced by Maya Peters, Cory Anderson and Angela Ulrich. 
 
